Erratum to “Synthesis, biological evaluation, and physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase inhibitors” (Bioorganic and Medicinal Chemistry (2016) 24(13) (3083–3092) (S0968089616303492) (10.1016/j.bmc.2016.05.025))

Sheng Biao Wang, Mu Tian Cui, Xiao Feng Wang, Emika Ohkoshi, Masuo Goto, De Xuan Yang, Linna Li, Shoujun Yuan, Susan L. Morris-Natschke, Kuo Hsiung Lee, Lan Xie

Research output: Contribution to journalComment/debate

Abstract

When this paper was first published there were errors in Tables 1 and 2. The data for the reference compounds staurosporine and paclitaxel were shifted one column to the left in error, and the activity entry given for staurosporine (0.083 micromolar) is incorrect. The correct tables are printed below. The publisher apologises that these errors which were not rectified before publication.

LanguageEnglish (US)
Pages2676-2678
Number of pages3
JournalBioorganic and Medicinal Chemistry
Volume25
Issue number9
DOIs
StatePublished - 2017

Fingerprint

Staurosporine
Pharmaceutical Chemistry
Protein-Tyrosine Kinases
Paclitaxel
Publications

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

@article{0874e779521e4f6b860e4e13b3a30901,
title = "Erratum to “Synthesis, biological evaluation, and physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase inhibitors” (Bioorganic and Medicinal Chemistry (2016) 24(13) (3083–3092) (S0968089616303492) (10.1016/j.bmc.2016.05.025))",
abstract = "When this paper was first published there were errors in Tables 1 and 2. The data for the reference compounds staurosporine and paclitaxel were shifted one column to the left in error, and the activity entry given for staurosporine (0.083 micromolar) is incorrect. The correct tables are printed below. The publisher apologises that these errors which were not rectified before publication.",
author = "Wang, {Sheng Biao} and Cui, {Mu Tian} and Wang, {Xiao Feng} and Emika Ohkoshi and Masuo Goto and Yang, {De Xuan} and Linna Li and Shoujun Yuan and Morris-Natschke, {Susan L.} and Lee, {Kuo Hsiung} and Lan Xie",
year = "2017",
doi = "10.1016/j.bmc.2017.03.044",
language = "English (US)",
volume = "25",
pages = "2676--2678",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Erratum to “Synthesis, biological evaluation, and physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase inhibitors” (Bioorganic and Medicinal Chemistry (2016) 24(13) (3083–3092) (S0968089616303492) (10.1016/j.bmc.2016.05.025))

AU - Wang, Sheng Biao

AU - Cui, Mu Tian

AU - Wang, Xiao Feng

AU - Ohkoshi, Emika

AU - Goto, Masuo

AU - Yang, De Xuan

AU - Li, Linna

AU - Yuan, Shoujun

AU - Morris-Natschke, Susan L.

AU - Lee, Kuo Hsiung

AU - Xie, Lan

PY - 2017

Y1 - 2017

N2 - When this paper was first published there were errors in Tables 1 and 2. The data for the reference compounds staurosporine and paclitaxel were shifted one column to the left in error, and the activity entry given for staurosporine (0.083 micromolar) is incorrect. The correct tables are printed below. The publisher apologises that these errors which were not rectified before publication.

AB - When this paper was first published there were errors in Tables 1 and 2. The data for the reference compounds staurosporine and paclitaxel were shifted one column to the left in error, and the activity entry given for staurosporine (0.083 micromolar) is incorrect. The correct tables are printed below. The publisher apologises that these errors which were not rectified before publication.

UR - http://www.scopus.com/inward/record.url?scp=85016464318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016464318&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2017.03.044

DO - 10.1016/j.bmc.2017.03.044

M3 - Comment/debate

VL - 25

SP - 2676

EP - 2678

JO - Bioorganic and Medicinal Chemistry

T2 - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 9

ER -